These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1673 related items for PubMed ID: 33316739

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
    Tu K, Li J, Mo H, Xian Y, Xu Q, Xiao X.
    Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification and validation of a novel immune-related signature associated with macrophages and CD8 T cell infiltration predicting overall survival for hepatocellular carcinoma.
    Huo J, Wu L, Zang Y.
    BMC Med Genomics; 2021 Sep 20; 14(1):232. PubMed ID: 34544391
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm.
    Wang T, Dai L, Shen S, Yang Y, Yang M, Yang X, Qiu Y, Wang W.
    Front Immunol; 2022 Sep 20; 13():843408. PubMed ID: 35693827
    [Abstract] [Full Text] [Related]

  • 13. The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma.
    Deng M, Sun S, Zhao R, Guan R, Zhang Z, Li S, Wei W, Guo R.
    Mol Med; 2022 Feb 05; 28(1):16. PubMed ID: 35123387
    [Abstract] [Full Text] [Related]

  • 14. WGCNA, LASSO and SVM Algorithm Revealed RAC1 Correlated M0 Macrophage and the Risk Score to Predict the Survival of Hepatocellular Carcinoma Patients.
    You JA, Gong Y, Wu Y, Jin L, Chi Q, Sun D.
    Front Genet; 2021 Feb 05; 12():730920. PubMed ID: 35493265
    [Abstract] [Full Text] [Related]

  • 15. A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients.
    Wang Z, Zhang N, Lv J, Ma C, Gu J, Du Y, Qiu Y, Zhang Z, Li M, Jiang Y, Zhao J, Du H, Zhang Z, Lu W, Zhang Y.
    Biomed Res Int; 2020 Feb 05; 2020():4037639. PubMed ID: 33163533
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A necroptosis-related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma.
    Chen J, Wang H, Zhou L, Liu Z, Chen H, Tan X.
    Cancer Med; 2022 Dec 05; 11(24):5079-5096. PubMed ID: 35560794
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
    Wang Y, Song F, Zhang X, Yang C.
    Oxid Med Cell Longev; 2022 Dec 05; 2022():1592905. PubMed ID: 35535359
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 84.